SEO URLwww.firestrike.ai/deals/tersera-therapeutics-esteve-acquisition-2026-1
acquisitionAnnounced · Jan 13, 2026biopharmaceuticalSource · CredibleArticle · Factual
Esteve acquires TerSera Therapeutics
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
—
Target
TerSera Therapeutics
Deerfield, Illinois
Acquirer
Esteve
Full Acquisition
Status
Pending
Esteve agreed to acquire TerSera Therapeutics. Reported deal value: Undisclosed. Status: Pending. Sector: biopharmaceutical. Target headquarters context: Deerfield, Illinois, United States.
This page summarizes publicly available information about the transaction as of 2026-01-13. Figures and status may change as filings and press coverage update.
1 min Catalan pharmaceutical company Esteve and US-based TerSera Therapeutics LLC have announced an agreement under which Esteve will acquire TerSera specialty infusion therapies business unit
Deal timeline
Announced
Jan 13, 2026 · en.ara.cat
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in biopharmaceutical. Figures and status may change as sources update.
Sources: en.ara.cat · Primary article · FireStrike proprietary index